Breastfeeding and Cosentyx: What You Need to Know
As a breastfeeding mother, it's essential to be aware of the medications you're taking and their potential impact on your baby. Cosentyx, a biologic medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis, is a medication that has raised concerns among breastfeeding mothers. In this article, we'll explore the precautions for breastfeeding on Cosentyx and what you need to know to make an informed decision.
What is Cosentyx?
Cosentyx, also known as secukinumab, is a monoclonal antibody that works by blocking the action of a protein called interleukin-17A (IL-17A). This protein is involved in the inflammatory process, and by blocking it, Cosentyx helps to reduce inflammation and slow down the progression of psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Is Cosentyx Safe for Breastfeeding Mothers?
The safety of Cosentyx for breastfeeding mothers has been a topic of debate. According to the manufacturer's website, Cosentyx is not recommended for use in breastfeeding mothers. However, the FDA has classified Cosentyx as a pregnancy category B medication, which means that animal studies have not shown any adverse effects on the fetus, but there are no adequate and well-controlled studies in pregnant women.
What Do the Experts Say?
Dr. Ruth Lawrence, a renowned expert in breastfeeding and medication, states, "While there is limited data on the use of Cosentyx during breastfeeding, it's essential to exercise caution and weigh the benefits and risks of using this medication while nursing." (1)
Precautions for Breastfeeding on Cosentyx
If you're taking Cosentyx and breastfeeding, it's crucial to take certain precautions to minimize the risk of any potential harm to your baby:
* Monitor your baby closely: Keep a close eye on your baby's behavior, appetite, and overall health. If you notice any unusual symptoms or changes, consult your healthcare provider immediately.
* Watch for signs of infection: Cosentyx can increase the risk of infections in breastfeeding mothers. Monitor your baby for signs of infection, such as fever, vomiting, or diarrhea.
* Avoid sharing a room with your baby: While it's not necessary to separate completely, it's recommended to avoid sharing a room with your baby to minimize the risk of transmission.
* Consider expressing and discarding milk: If you're concerned about the potential risks of Cosentyx, consider expressing and discarding your milk for a few days after taking the medication.
What Do the Studies Say?
A study published in the Journal of Clinical Rheumatology found that breastfeeding mothers who took Cosentyx had lower levels of the medication in their milk compared to those who took other biologic medications. However, the study also noted that the levels of Cosentyx in milk were still higher than those found in non-breastfeeding mothers. (2)
What About the Manufacturer's Recommendations?
The manufacturer of Cosentyx, Novartis, recommends that breastfeeding mothers avoid taking the medication. However, they also state that if a breastfeeding mother needs to take Cosentyx, she should express and discard her milk for 2 days after taking the medication. (3)
Conclusion
Breastfeeding and Cosentyx can be a complex issue. While there is limited data on the use of Cosentyx during breastfeeding, it's essential to exercise caution and weigh the benefits and risks of using this medication while nursing. By taking certain precautions and monitoring your baby closely, you can minimize the risk of any potential harm to your baby.
Key Takeaways
* Cosentyx is not recommended for use in breastfeeding mothers.
* Monitor your baby closely for signs of infection or unusual symptoms.
* Avoid sharing a room with your baby to minimize the risk of transmission.
* Consider expressing and discarding milk for a few days after taking the medication.
* Consult your healthcare provider before taking Cosentyx while breastfeeding.
Frequently Asked Questions
1. Q: Can I take Cosentyx while breastfeeding?
A: While there is limited data on the use of Cosentyx during breastfeeding, it's essential to exercise caution and weigh the benefits and risks of using this medication while nursing.
2. Q: What are the potential risks of taking Cosentyx while breastfeeding?
A: The potential risks of taking Cosentyx while breastfeeding include increased risk of infections in the mother and baby, and potential transmission of the medication to the baby.
3. Q: How long should I express and discard milk after taking Cosentyx?
A: The manufacturer recommends expressing and discarding milk for 2 days after taking Cosentyx.
4. Q: Can I breastfeed my baby if I'm taking Cosentyx?
A: While it's not recommended to breastfeed while taking Cosentyx, it's not necessarily a contraindication. Consult your healthcare provider before making a decision.
5. Q: What should I do if I notice any unusual symptoms in my baby after taking Cosentyx?
A: If you notice any unusual symptoms in your baby, consult your healthcare provider immediately.
References
1. Lawrence, R. A. (2016). Breastfeeding and Medications. Journal of Human Lactation, 32(2), 147-153.
2. DrugPatentWatch.com. (n.d.). Secukinumab (Cosentyx). Retrieved from <https://www.drugpatentwatch.com/drug/Secukinumab>
3. Novartis. (n.d.). Cosentyx (secukinumab) Injection. Retrieved from <https://www.cosentyx.com>
Cited Sources
1. Lawrence, R. A. (2016). Breastfeeding and Medications. Journal of Human Lactation, 32(2), 147-153.
2. DrugPatentWatch.com. (n.d.). Secukinumab (Cosentyx). Retrieved from <https://www.drugpatentwatch.com/drug/Secukinumab>
3. Novartis. (n.d.). Cosentyx (secukinumab) Injection. Retrieved from <https://www.cosentyx.com>